Spiro R G, Bhoyroo V D
Department of Biological Chemistry and Medicine (Harvard Medical School) and Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA.
Biochem J. 1998 Apr 1;331 ( Pt 1)(Pt 1):265-71. doi: 10.1042/bj3310265.
An enzyme which catalyses the transfer of sulphate from 3'-phosphoadenosine 5'-phosphosulphate (PAPS) to C-6 of galactose in the NeuAcalpha2-3Galbeta1-4GlcNAc (3'SLN) sequence has been found in rat spleen microsomes and its specificity indicates that it is well suited to participate in the assembly of 3'-sialyl-6'-sulpho-LacNAc [NeuAcalpha2-3Gal(6-SO4)beta1-4GlcNAc] and 3'-sialyl-6'-sulpho-LewisX [NeuAcalpha2-3Gal(6-SO4)beta1-4(Fucalpha1-3)GlcNAc] saccharide groups which have been implicated as selectin ligands. This sulphotransferase has a strict requirement for oligosaccharide acceptors which are capped by an alpha2-3-linked sialic acid residue, although GlcNAc in 3'SLN can be substituted by Glc, and Galbeta1-4GlcNAc can be replaced by Galbeta1-3GlcNAc without loss of activity. The finding that 3'-sialyl LewisX was inert as an acceptor suggested that fucosylation, in contrast with sialylation, follows the addition of the sulphate group. Since fetuin glycopeptides containing the NeuAcalpha2-3Galbeta1-4GlcNAc sequence had a similar affinity for the enzyme as the unattached 3'SLN, it would appear that the acceptor determinants reside primarily in the peripheral trisaccharide constellation. The position of the sulphate on C-6 of galactose was elucidated by Smith periodate oxidation, hydrazine/nitrous acid/NaBH4 treatment and elder (Sambucus nigra) bark lectin chromatography of the desialylated [35S]sulphate-labelled products of the enzyme. Assays carried out with 3'SLN as acceptor indicated that the sulphotransferase had a pH optimum between 6.5 and 7.0 and a dependence on a bivalent cation best met by Mn2+ (12-25 mM); Triton X-100 (0.02 to 0.35%) brought about maximal stimulation. Tentative Km values determined for this enzyme were 4.7 microM for PAPS, and 0.72 mM and 1.16 mM for 3'SLN and fetuin glycopeptides respectively. A survey of several rat organs indicated that the PAPS:3'SLN-6-O-sulphotransferase is selectively distributed with maximal activity occurring in spleen which was substantially greater than thymus or lymph nodes. In contrast, other enzymes (i.e. PAPS:Gal-3-O-and GlcNAc-6-O-sulphotransferases) involved in the sulphation of sialyl-lactosamine and lactosamine sequences, which in the sulphated form are believed to also be selectin ligands, were more evenly distributed in lymphoid tissues. Relatively high activities for all three enzymes were found in brain.
在大鼠脾脏微粒体中发现了一种酶,它能催化将硫酸基团从3'-磷酸腺苷5'-磷酸硫酸酯(PAPS)转移至NeuAcalpha2-3Galbeta1-4GlcNAc(3'SLN)序列中半乳糖的C-6位。其特异性表明,它非常适合参与3'-唾液酸基-6'-硫酸化乳糖胺[NeuAcalpha2-3Gal(6-SO4)beta1-4GlcNAc]和3'-唾液酸基-6'-硫酸化路易斯X[NeuAcalpha2-3Gal(6-SO4)beta1-4(Fucalpha1-3)GlcNAc]糖基团的组装,这些糖基团被认为是选择素配体。这种磺基转移酶对由α2-3连接的唾液酸残基封端的寡糖受体有严格要求,尽管3'SLN中的GlcNAc可被Glc取代,且Galbeta1-4GlcNAc可被Galbeta1-3GlcNAc替代而不丧失活性。3'-唾液酸路易斯X作为受体呈惰性这一发现表明,与唾液酸化相反,岩藻糖基化是在硫酸基团添加之后发生的。由于含有NeuAcalpha2-3Galbeta1-4GlcNAc序列的胎球蛋白糖肽对该酶的亲和力与游离的3'SLN相似,因此受体决定簇似乎主要存在于外周三糖结构中。通过对该酶的去唾液酸化[35S]硫酸标记产物进行高碘酸-史密斯氧化、肼/亚硝酸/NaBH4处理以及接骨木(黑接骨木)树皮凝集素层析,阐明了半乳糖C-6位上硫酸基团的位置。以3'SLN作为受体进行的测定表明,该磺基转移酶的最适pH在6.5至7.0之间,对二价阳离子的依赖性以Mn2+(12 - 25 mM)最佳满足;Triton X-100(0.02%至0.35%)可带来最大刺激。该酶的初步Km值分别为:PAPS为4.7 microM,3'SLN为0.72 mM,胎球蛋白糖肽为1.16 mM。对几种大鼠器官的调查表明,PAPS:3'SLN-6-O-磺基转移酶选择性分布,在脾脏中活性最高,显著高于胸腺或淋巴结。相比之下,参与唾液酸乳糖胺和乳糖胺序列硫酸化的其他酶(即PAPS:Gal-3-O-和GlcNAc-6-O-磺基转移酶),其硫酸化形式也被认为是选择素配体,在淋巴组织中分布更为均匀。在脑中发现这三种酶的活性都相对较高。